KEMADRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kemadrin, and when can generic versions of Kemadrin launch?
Kemadrin is a drug marketed by Monarch Pharms and is included in one NDA.
The generic ingredient in KEMADRIN is procyclidine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the procyclidine hydrochloride profile page.
Summary for KEMADRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 2,690 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KEMADRIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KEMADRIN
US Patents and Regulatory Information for KEMADRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monarch Pharms | KEMADRIN | procyclidine hydrochloride | TABLET;ORAL | 009818-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Monarch Pharms | KEMADRIN | procyclidine hydrochloride | TABLET;ORAL | 009818-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |